MedPath
FDA Approval

Meclizine Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Epic Pharma LLC
DUNS: 827915443
Effective Date
August 21, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Meclizine(12.5 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Epic Pharm LLC

827915443

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Epic Pharma LLC

Epic Pharma LLC

Epic Pharm LLC

827915443

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Meclizine Hydrochloride

Product Details

NDC Product Code
42806-012
Application Number
ANDA200294
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 21, 2020
MeclizineActive
Code: HDP7W44CIOClass: ACTIBQuantity: 12.5 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBDClass: IACT

Meclizine Hydrochloride

Product Details

NDC Product Code
42806-014
Application Number
ANDA200294
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 21, 2020
MeclizineActive
Code: HDP7W44CIOClass: ACTIBQuantity: 25 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath